261 related articles for article (PubMed ID: 26172047)
21. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle.
Wang G; Biswas AK; Ma W; Kandpal M; Coker C; Grandgenett PM; Hollingsworth MA; Jain R; Tanji K; Lόpez-Pintado S; Borczuk A; Hebert D; Jenkitkasemwong S; Hojyo S; Davuluri RV; Knutson MD; Fukada T; Acharyya S
Nat Med; 2018 Jun; 24(6):770-781. PubMed ID: 29875463
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
Gresham G; Placencio-Hickok VR; Lauzon M; Nguyen T; Kim H; Mehta S; Paski S; Pandol SJ; Osipov A; Gong J; Jamil LH; Nissen N; Lo SK; Hendifar AE
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1959-1968. PubMed ID: 34609081
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-β Signaling Axis in Pancreatic Cancer.
Shi X; Yang J; Liu M; Zhang Y; Zhou Z; Luo W; Fung KM; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2022 Jun; 162(7):2004-2017.e2. PubMed ID: 35176309
[TBL] [Abstract][Full Text] [Related]
24. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
[TBL] [Abstract][Full Text] [Related]
25. Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia.
Olson B; Zhu X; Norgard MA; Levasseur PR; Butler JT; Buenafe A; Burfeind KG; Michaelis KA; Pelz KR; Mendez H; Edwards J; Krasnow SM; Grossberg AJ; Marks DL
Nat Commun; 2021 Apr; 12(1):2057. PubMed ID: 33824339
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic Cancer-Induced Cachexia and Relevant Mouse Models.
Henderson SE; Makhijani N; Mace TA
Pancreas; 2018 Sep; 47(8):937-945. PubMed ID: 30113428
[TBL] [Abstract][Full Text] [Related]
27. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
[TBL] [Abstract][Full Text] [Related]
28. Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting.
Wyart E; Reano S; Hsu MY; Longo DL; Li M; Hirsch E; Filigheddu N; Ghigo A; Riganti C; Porporato PE
Oxid Med Cell Longev; 2018; 2018():6419805. PubMed ID: 29682162
[TBL] [Abstract][Full Text] [Related]
29. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia.
Cui P; Shao W; Huang C; Wu CJ; Jiang B; Lin D
Skelet Muscle; 2019 Jan; 9(1):3. PubMed ID: 30635036
[TBL] [Abstract][Full Text] [Related]
30. Tumor inoculation site affects the development of cancer cachexia and muscle wasting.
Matsuyama T; Ishikawa T; Okayama T; Oka K; Adachi S; Mizushima K; Kimura R; Okajima M; Sakai H; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Kokura S; Naito Y; Itoh Y
Int J Cancer; 2015 Dec; 137(11):2558-65. PubMed ID: 26016447
[TBL] [Abstract][Full Text] [Related]
31. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Markov SD; Gonzalez D; Mehla K
Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
[TBL] [Abstract][Full Text] [Related]
32. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
33. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.
Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N
Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.
Nyman JS; Merkel AR; Uppuganti S; Nayak B; Rowland B; Makowski AJ; Oyajobi BO; Sterling JA
Bone; 2016 Oct; 91():81-91. PubMed ID: 27423464
[TBL] [Abstract][Full Text] [Related]
35. A novel orthotopic mouse model replicates human lung cancer cachexia.
van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
[TBL] [Abstract][Full Text] [Related]
36. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
[TBL] [Abstract][Full Text] [Related]
37. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
[TBL] [Abstract][Full Text] [Related]
38. Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function.
Penna F; Ballarò R; Martinez-Cristobal P; Sala D; Sebastian D; Busquets S; Muscaritoli M; Argilés JM; Costelli P; Zorzano A
J Mol Biol; 2019 Jul; 431(15):2674-2686. PubMed ID: 31150737
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer cachexia: three dimensions of a complex syndrome.
Kordes M; Larsson L; Engstrand L; Löhr JM
Br J Cancer; 2021 May; 124(10):1623-1636. PubMed ID: 33742145
[TBL] [Abstract][Full Text] [Related]
40. Cancer cachexia.
Tisdale MJ
Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
